PPCB stock Statistics — Propanc Biopharma, Inc. filings, insiders & smart money

Price chart (1D to 10Y)

Licensed market data — shown to members, not published to the open web.

Beta: Sign in
Shares outstandingAs of 2026-09-23 · filed common shares: 6.33M
Shares float: Sign in
Float %: Sign in
Insider ownership: —
Institutional ownership: Sign in
Short interestShare of shares outstanding, at settlement: 5.31%
Short ratioDays to cover, as published by FINRA: 1.00
Short volume (5D)Share of FINRA reporting-facility volume sold short, daily flow: 45.00%
Short volume (20D)Share of FINRA reporting-facility volume sold short, daily flow: 44.60%
Avg volume (10D)

Source: SEC filings. Information and analytics, not investment advice.

Rev growth (fwd)

Avg volume (3 months)

Gross margin: —
Operating margin: —
Net margin: —
EBITDA margin: —
Return on equityNet income (FY Jun 26) ÷ average shareholders equity: -161.86%
Return on assetsNet income (FY Jun 26) ÷ average total assets: -116.39%

Cash & equivalentsas of Jun 26: $832.00K
Total cash: Sign in
Total debtBorrowings + finance and operating lease liabilities, as of Jun 26: $48.30K
Debt / equityas of Jun 26: 0.51%
Current ratioas of Jun 26: 2.55
Quick ratio: —
Operating cash flowFY Jun 26: -$5.68M
Free cash flowUnadjusted FCF = CFO − capex · FY Jun 26: -$5.68M
TTM revenue / diluted share: —